Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
Jamal Rana, Assistant Physician in Chief at The Permanente Medical Group, in Pleasanton, California, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Our another exciting paper, led by Iribarren, published in American Journal of Preventive Cardiology. Interplay between family history and polygenic risk for coronary heart disease (CHD).
Family history of heart disease is a recognized risk factor. However, it is considered to have low accuracy due to recall bias. Likely reason it is not part of the risk factor base risk calculators such as PREVENT.
Cohort comprised of 61,352 individuals from Kaiser Permanente with follow-up time of 14 years.
Individuals underwent polygenic risk scoring PRS (CARDIO inCode-Score CHD PRS, GENinCode Plc).
PRS and family history CHD were positively correlated, and both independently contribute to risk of incident CHD.
High PRS was associated with similar increased CHD risk in persons with and without family history CHD. A key finding of this study is therefore the fact that PRS adds to risk information among individuals with negative family history.
Hazard ratio, due to joint effect of positive family history CHD and high PRS was well above two.
These results have important clinical implications because relying solely on self-reported family history is insufficient to fully characterize the genetic contribution to CHD and thus the use of PRS could complement traditional risk algorithms particularly among subjects with no known family history of CHD.”
Title: Interplay between family history and polygenic risk for coronary heart disease: A cohort study among over 60 thousand individuals
Authors: Carlos Iribarren, Meng Lu, Roberto Elosua, Martha Gulati, Nathan D. Wong, Jamal S.Rana
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size